Sort
64,565 grants matching “drug discovery”
In vivo Probe for ionotropic glutamate signaling system: AMPA receptors
$719,969Steven H Liang · Massachusetts General Hospital · R01 · FY2019 · MH
Organs-on-Chips as a Platform for Studying Effects of Microgravity on Human Physiology: Blood-Brain Barrier-Chip in Health and Disease
$719,900Christopher D. Hinojosa · Emulate, Inc. · UG3 · FY2017 · TR
Early Clinical Trials of New Anti-Cancer Agents with Phase I Emphasis
$719,853Afshin Dowlati · Case Western Reserve University · U01 · FY2010 · CA
PHARMACOGENOMICS OF ACAMPROSATE TREATMENT OUTCOME
$719,820Victor M. Karpyak · Mayo Clinic Rochester · U01 · FY2020 · AA
HIV-Hepatitis C Virus Cooperative Interactions and Liver Disease Progression
$719,784Raymond T Chung · Massachusetts General Hospital · R01 · FY2015 · DK
Natural Resistance to Mycobacterium Tuberculosis Infection
$719,693W. Henry Henry Boom · Case Western Reserve University · U01 · FY2015 · AI
Drug Discovery for Human African Trypanosomiasis
$719,679Michael H Gelb · University Of Washington · R01 · FY2014 · AI
Drug Discovery for Human African Trypanosomiasis
$719,679Michael H Gelb · University Of Washington · R01 · FY2015 · AI
Salmonella-specific therapeutics
$719,497Brian M Ahmer · Ohio State University · R01 · FY2019 · AI
Microphysiological systems to model vascular malformations
$719,442Christopher C. W. Hughes · University Of California-Irvine · UG3 · FY2018 · HL
Developmental and Translational Pharmacology of Pediatric Antimicrobial Therapy
$719,439Edmund Vincent Capparelli · University Of California, San Diego · U54 · FY2015 · HD
Urinary Proteome Monitoring for Transplant Injury
$719,327Minnie M Sarwal · Stanford University · R01 · FY2010 · DK
Discovery of Pharmacogenomic Biomarkers for Metformin Response
$719,085Kathleen M Giacomini · University Of California, San Francisco · R01 · FY2017 · GM
Targeting RIPK3 in Flu-Associated Lung Injury
$719,078Siddharth Balachandran · Research Inst Of Fox Chase Can Ctr · R01 · FY2019 · AI
Genetic and Clinical Predictors of Response to Warfarin and Novel Anticoagulants
$719,078Nita A Limdi · University Of Alabama At Birmingham · R01 · FY2016 · HL
New Signaling Networks in Vascular Smooth Muscle
$719,071Avril V. Somlyo · University Of Virginia · R01 · FY2022 · HL
A microED pipeline for the pharmaceutical and biotechnology industry
$719,038Giovanna Scapin · Nanoimaging Services, Inc. · R44 · FY2021 · GM
Developing novel strategies for personalized treatment and prevention of ALS: Leveraging the global exposome, genome, epigenome, metabolome, and inflammasome with data science in a case/control cohort
$719,029Eva L Feldman · University Of Michigan At Ann Arbor · R01 · FY2024 · NS
Small Molecule Therapeutics for Myocardial Ischemia
$718,826Prakash Narayan · Angion Biomedica Corporation · R44 · FY2007 · HL
Pharmacogenetics and Cardiovascular Events
$718,681University Of Washington · R01 · FY2004 · HL
Evaluating the Functional Impact of Genetic Diversity on Malaria Vaccine Candidates
$718,581Amy Kristine Bei · Yale University · R01 · FY2023 · AI
Antibacterial inhibitors of RnpA
$718,534Paul M. Dunman · University Of Rochester · R01 · FY2019 · AI
Linkage-specific ubiquitylation patterns as highly sensitive markers for neurodegenerative disease
$718,511Tauseef R. Butt · Lifesensors, Inc. · R44 · FY2018 · AG
Bacterial and Molecular Determinants of Mycobacterial Impermeability
$718,478Marcos M. Pires · University Of Virginia · R01 · FY2025 · AI
Structural Analysis of Biological Membrane Proteins
$718,414Di S Xia · Division Of Basic Sciences - Nci · ZIA · FY2013 · CA